M.D., Chief Medical Officer, Bavarian Nordic
Dr. Christopher Heery is the Chief Medical Officer for Bavarian Nordic where he oversees the clinical development of BN’s pipeline, comprising therapeutic cancer vaccines and vaccines for prevention of infectious diseases. He is a medical oncologist by training. He trained at the National Cancer Institute in the Laboratory of Tumor Immunology and Biology, where he went on to be the Head of the Clinical Trials group in that translational ImmunoOncology-focused branch. He has personally run a wide variety of immunotherapy trials using a variety of first-in-human agents including therapeutic cancer vaccines, checkpoint inhibitors, antibody-cytokine conjugates, and cytokine targeting antibodies. His trial experience also includes combination strategies in IO and IO with standard therapies based on mechanistic rationale.
Presentation Title and Company Description
Immunotherapy Showcase: Poxviral Vaccines to Drive Immune Response
Bavarian Nordic is a fully integrated biotech focused on a poxviral vaccine platform which can be modified for the potential purposes of prevention of infectious diseases or treatment of cancer. Bavarian collaborates with both large pharma and government institutions.